Zetia and Silver drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zetia (ezetimibe) and Silver (colloidal silver). Common drug interactions include dyspnoea among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Zetia and Silver. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Zetia?

Zetia has active ingredients of ezetimibe. It is often used in high blood cholesterol. eHealthMe is studying from 49,113 Zetia users. Check the latest studies of Zetia.

What is Silver?

Silver has active ingredients of colloidal silver. eHealthMe is studying from 1,674 Silver users. Check the latest studies of Silver.



On Jul, 11, 2026

19 people who take Zetia and Silver together, and have interactions are studied.

Zetia and Silver drug interactions.

What are the common drug interactions of Zetia and Silver, by gender? *:

female:

  1. Dyspnoea (difficult or laboured respiration)
  2. Speech disorder
  3. Contusion (a type of hematoma of tissue in which capillaries)
  4. Death
  5. Dysphonia (speech disorder attributable to a disorder of phonation)
  6. Pain in extremity
  7. Peripheral swelling
  8. Vascular rupture
  9. Abdominal pain
  10. Acute respiratory failure

male:

  1. Pneumonia
  2. Balance disorder
  3. Musculoskeletal discomfort (discomfort in the body's muscles, joints, tendons, ligaments and nerves)
  4. Productive cough
  5. Scratch
  6. Syncope (loss of consciousness with an inability to maintain postural tone)
  7. Tremor (trembling or shaking movements in one or more parts of your body)
  8. Chronic kidney disease
  9. Decreased appetite
  10. Nephrogenic anaemia (anaemia due to kidney disease)

What are the common drug interactions of Zetia and Silver, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Abdominal pain
  2. Anxiety
  3. Cardiac failure
  4. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  5. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  6. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  7. Emotional distress
  8. General physical health deterioration (weak health status)
  9. Injury
  10. Pain

50-59:

  1. Contusion (a type of hematoma of tissue in which capillaries)
  2. Pain in extremity
  3. Peripheral swelling
  4. Vascular rupture
  5. Ecchymosis (a discoloration of the skin resulting from bleeding underneath)
  6. Hyperhidrosis (abnormally increased sweating)
  7. Insomnia (sleeplessness)
  8. Nocturia (the need to get up in the night to urinate)
  9. Pneumonia
  10. Reflux gastritis (a condition in which the lining of a person's stomach becomes inflamed as a result of exposure to bile)

60+:

  1. Dyspnoea (difficult or laboured respiration)
  2. Speech disorder
  3. Anaemia of chronic disease
  4. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  5. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  6. Hospitalisation
  7. Hypernatraemia (an abnormally high plasma concentration of sodium ions)
  8. Hypoxic-ischaemic encephalopathy (a condition that occurs when the entire brain is deprived of an adequate oxygen supply, but the deprivation isn't total)
  9. Pneumonia
  10. Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 31.58%
  2. Impaired Gastric Emptying: 4 people, 21.05%
  3. Immunodeficiency Common Variable: 3 people, 15.79%
  4. Cardiac Disorder: 2 people, 10.53%
  5. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 10.53%
  6. Diabetes: 2 people, 10.53%
  7. Fluid Retention (an abnormal accumulation of fluid in the blood): 2 people, 10.53%
  8. Vitamin E Deficiency: 2 people, 10.53%
  9. Inflammation: 2 people, 10.53%
  10. Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 2 people, 10.53%

* Approximation only. Some reports may have incomplete information.

Do you take Zetia and Silver?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Zetia and Silver:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Zetia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Silver:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zetia and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Silver and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ezetimibe and colloidal silver (the active ingredients of Zetia and Silver, respectively), and Zetia and Silver (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: